Cancer Audit Programme Manager
The Cancer Audit Programme at St. James’s Hospital was established in 2001. Its goal is to provide comprehensive prospective data on the structures, processes and outcomes of cancer care provided by the hospital’s many cancer specialities. Available outcome data provides information to patients, enables audit and continuous improving of service and allows for benchmarking against best international practices. This information also informs the hospital’s administration and board, the Health Service Executive and the Department of Health on quality aspects of cancer care and contributes to cost estimates. In 2013, the Cancer Audit Department was integral to the provision of information to the National Cancer Control Programme (NCCP) and the Health Information and Quality Authority. The Hospital registry structure also enables the research function of the academic centre, Trinity College.
Cancer Audit Structure
The Cancer Audit Programme is managed by a Cancer Audit Manager, with dedicated cancer data managers in each department: lung, oesophageal/gastric, gynaecology breast, haematology, colorectal and head and neck. Each data manager reports to both the Cancer Audit Manager and the consultant clinical lead directly responsible for each cancer. The programme is clinically driven by the Cancer Audit Director, working directly with the CEO office. The technical function is directly supported by the Information Management Services Department. There are also a number of other cancer registries that supplement cancer care in the hospital, including the Breast Clinic, Rapid Access Prostate Clinic, Barretts Oesophagus, and Cancer Clinical Trials.
The department’s first report was in 2004; a six-year report of incidence and outcome cancer data was produced in 2008, the first report of its kind in Ireland. One of the recent key developments within the cancer audit field is the introduction of tumour site-specific Quality Improvement Programmes (QIP). A key aim of the QIP is to monitor and improve each service to ensure the continuous provision of safe, effective, quality cancer care as well as compliance with all relevant legislation, regulation and national and international best practice standards. The QIP provides a platform for validation, review and quality assurance of the cancer data. Most importantly, it facilitates in-house and the National Cancer Control Programme’s Key Performance Indicators that monitor the quality of the cancer service. The programme seeks to develop a framework for and to foster a culture of continuous quality improvement in the delivery of cancer care.